Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.
Open Access
- 1 May 1982
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 23 (4) , 627-630
- https://doi.org/10.1016/s0022-2275(20)38127-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Cholest-5-ene-3β,26-diol: Synthesis and biomedical use of a deuterated compoundJournal of Mass Spectrometry, 1982
- Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid in the hamster.Journal of Biological Chemistry, 1981
- Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.Journal of Clinical Investigation, 1980
- Rat liver mitochondrial cytochrome P-450—A C27-steroid 26-hydroxylaseThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- ω‐Hydroxylation of Steroid Side‐Chain in Biosynthesis of Bile AcidsEuropean Journal of Biochemistry, 1973
- Bile Acid Synthesis in Man: Metabolism of 7α-Hydroxycholesterol-14C and 26-Hydroxycholesterol-3HJournal of Clinical Investigation, 1972
- Quantitative estimation of bile salts in serumCanadian Journal of Biochemistry, 1970
- Sterol Metabolism. I. 26-Hydroxycholesterol in the Human Aorta*Biochemistry, 1967
- 5-Cholestene-3β,26-diolJournal of the American Chemical Society, 1956
- A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITYJournal of Biological Chemistry, 1952